StockData
Intelligent Bio Solutions Inc. logo

Intelligent Bio Solutions Inc. (INBS) shareholders

INBSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3057% below fair value
$1.56+0.06 (+4.00%)

Close on Nov 17, 2026Market cap $4.72MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
6.0%
0M of 3M shares
Institutional holders
8
1 new, 2 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Anand Parekh
Joint filing with Alyeska Investment Group, L.P. (9.99%), Alyeska Fund GP, LLC (9.99%)
944,3109.99%13G (passive) amendmentSep 30, 2025
Steven Boyd
Joint filing with Armistice Capital, LLC (5.91%)
141,3975.91%13G (passive) amendmentJun 30, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of INBSValueChange% of portfolio
Armistice Capital, LLC141,3974.67%$324.51K+11,3970.00%
Geode Capital Management, LLC20,8400.69%$47.83K−7,7690.00%
Vanguard Capital Management LLC5,8100.19%$13.33K–0.00%
UBS Group AG5,7350.19%$13.16K+5,3630.00%
Vanguard Fiduciary Trust Co3,9580.13%$9.08K–0.00%
Tower Research Capital LLC (TRC)3,2800.11%$7.53K+2,0300.00%
Osaic Holdings, Inc.2000.01%$460–0.00%
Barclays PLC1420.00%$326New0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202680M6.0%1 / 31 / 20M0M
Q1 202690M6.9%6 / 02 / 40M0M
Q4 202570M0.2%7 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

5 funds held INBS in Q2 2026, 28% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of INBSValue% of fundAs of
Fidelity Extended Market Index Fund12,5450.41%$32.24K0.00%May 31, 2026
Vanguard Extended Market Index Fund5,8100.19%$13.33K0.00%Jun 30, 2026
Fidelity Series Total Market Index Fund1,7690.06%$4.55K0.00%May 31, 2026
Fidelity Total Market Index Fund4090.01%$1.05K0.00%May 31, 2026
Blackstone Alternative Multi-Strategy Fund-30-0.00%-$69-0.00%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Harry SimeonidisChief Executive Officer34,5401.14%Mar 20, 2026
Spiro Kevin SakirisChief Financial Officer35,8921.19%Mar 20, 2026
Steven Constantine BoyagesDirector5,0310.17%Mar 20, 2026
Jonathan Scott HurdDirector5,0060.17%Mar 20, 2026
Jason IsenbergDirector5,0000.17%Mar 20, 2026
Nicola Marion FraserDirector5,0000.17%Mar 20, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Harry Simeonidis
Chief Executive Officer
Mar 18, 2026Award+21,350––34,540
Harry Simeonidis
Chief Executive Officer
Mar 18, 2026Award+9,150––13,190
Jason Isenberg
Director
Mar 18, 2026Award+5,000––5,000
Steven Constantine Boyages
Director
Mar 18, 2026Award+5,000––5,031
Jonathan Scott Hurd
Director
Mar 18, 2026Award+5,000––5,006
Nicola Marion Fraser
Director
Mar 18, 2026Award+5,000––5,000
Spiro Kevin Sakiris
Chief Financial Officer
Mar 18, 2026Award+21,350––33,981
Spiro Kevin Sakiris
Chief Financial Officer
Mar 18, 2026Award+9,150––12,631
Spiro Kevin Sakiris
Chief Financial Officer
Sep 25, 2024Award+34,500––34,815
Spiro Kevin Sakiris
Chief Financial Officer
Sep 25, 2024Award+34,500––34,815
Harry Simeonidis
Chief Executive Officer
Sep 25, 2024Award+40,000––40,408
Spiro Kevin Sakiris
Chief Financial Officer
Mar 20, 2024Option exercise+9,394––19,180
Spiro Kevin Sakiris
Chief Financial Officer
Oct 4, 2023Buy+112,727––117,427
Christopher Towers
Director
Oct 4, 2023Buy+9,090––9,880
Harry Simeonidis
CEO
Sep 1, 2023Buy+50$1.85$934,180
Harry Simeonidis
CEO
Aug 31, 2023Buy+100$1.92$1924,130
Spiro Kevin Sakiris
Chief Financial Officer
May 10, 2023Conversion+2,399$5.80$13.91K4,745
Spiro Kevin Sakiris
Chief Financial Officer
Oct 10, 2022Award+75,000––125,228
George Margelis
Director
Oct 10, 2022Award+15,000––15,000
Harry Simeonidis
President
Oct 10, 2022Award+80,000––80,600
Jonathan Scott Hurd
Director
Oct 10, 2022Award+15,000––15,000
Christopher Towers
Director
Oct 10, 2022Award+15,000––15,800
Steven Constantine Boyages
Interim CEO and Chairperson, Director
Oct 10, 2022Award+75,000––75,000
Lawrence B. Fisher
Director
Oct 10, 2022Award+15,000––15,000
Spiro Kevin Sakiris
Chief Financial Officer
Jun 22, 2022Buy+5,000$0.65$3.25K50,228
Spiro Kevin Sakiris
ChiefFinancial Officer
Jun 17, 2022Buy+15,970$0.61$9.74K45,228
Science Biosensor Diagnostics Pty Ltd Life
–
Feb 17, 2022Sale−576,028$0.51$293.77K1,081,804
Science Biosensor Diagnostics Pty Ltd Life
10% owner
Feb 16, 2022Sale−100,000$0.63$63.00K1,657,832
Science Biosensor Diagnostics Pty Ltd Life
10% owner
Feb 15, 2022Sale−100,000$0.68$68.00K1,757,832
Science Biosensor Diagnostics Pty Ltd Life
10% owner
Feb 14, 2022Sale−100,000$0.70$70.00K1,857,832
Science Biosensor Diagnostics Pty Ltd Life
10% owner
Feb 11, 2022Sale−100,000$0.75$75.00K1,957,832
Science Biosensor Diagnostics Pty Ltd Life
10% owner
Feb 10, 2022Sale−100,000$0.84$84.00K2,057,832
Science Biosensor Diagnostics Pty Ltd Life
10% owner
Feb 9, 2022Sale−100,000$0.86$86.00K2,157,832
Science Biosensor Diagnostics Pty Ltd Life
10% owner
Feb 8, 2022Sale−100,000$0.89$89.00K2,257,832
Science Biosensor Diagnostics Pty Ltd Life
10% owner
Feb 2, 2022Sale−100,000$0.92$92.00K2,357,832
Science Biosensor Diagnostics Pty Ltd Life
10% owner
Jan 31, 2022Sale−100,000$0.90$90.00K2,457,832
Science Biosensor Diagnostics Pty Ltd Life
10% owner
Jan 28, 2022Sale−100,000$0.92$92.00K2,557,832
Science Biosensor Diagnostics Pty Ltd Life
10% owner
Jan 27, 2022Sale−100,000$1.00$100.00K2,657,832
Tom Parmakellis
Director
Dec 30, 2021Buy+4,500$1.55$6.98K9,300
Science Biosensor Diagnostics Pty Ltd Life
10% owner
Dec 17, 2021Sale−200,000$1.49$298.00K2,757,832
Tom Parmakellis
Director
Dec 16, 2021Buy+2,800$1.69$4.73K4,800
Spiro Kevin Sakiris
ChiefFinancial Officer
Dec 6, 2021Buy+10,000$1.70$17.00K29,258
Science Biosensor Diagnostics Pty Ltd Life
10% owner
Nov 30, 2021Sale−250,000$1.87$467.50K2,957,832
Science Biosensor Diagnostics Pty Ltd Life
10% owner
Nov 29, 2021Sale−100,000$1.69$169.00K3,207,832
Science Biosensor Diagnostics Pty Ltd Life
10% owner
Nov 24, 2021Sale−100,000$1.64$164.00K3,307,832
Science Biosensor Diagnostics Pty Ltd Life
10% owner
Nov 9, 2021Sale−300,000$2.02$606.00K3,407,832
Science Biosensor Diagnostics Pty Ltd Life
10% owner
Oct 21, 2021Sale−248,416$2.26$561.42K3,707,832
Science Biosensor Diagnostics Pty Ltd Life
10% owner
Oct 20, 2021Sale−24,209$2.25$54.47K3,956,248
Science Biosensor Diagnostics Pty Ltd Life
10% owner
Oct 19, 2021Sale−16,326$2.25$36.73K3,980,457
Science Biosensor Diagnostics Pty Ltd Life
10% owner
Oct 14, 2021Sale−100,726$2.18$219.58K3,996,783
Science Biosensor Diagnostics Pty Ltd Life
10% owner
Oct 13, 2021Sale−58,739$2.25$132.16K4,097,509
Science Biosensor Diagnostics Pty Ltd Life
10% owner
Oct 12, 2021Sale−100,000$2.13$213.00K4,156,248
Science Biosensor Diagnostics Pty Ltd Life
10% owner
Oct 8, 2021Sale−200,000$2.30$460.00K4,256,248
Tom Parmakellis
Director
Sep 28, 2021Buy+1,000$2.40$2.40K2,000
Science Biosensor Diagnostics Pty Ltd Life
10% owner
Sep 28, 2021Sale−200,000$2.48$496.00K4,456,248
Science Biosensor Diagnostics Pty Ltd Life
10% owner
Sep 24, 2021Sale−200,000$2.66$532.00K4,656,248
Science Biosensor Diagnostics Pty Ltd Life
10% owner
Sep 23, 2021Sale−100,000$2.77$277.00K4,856,248
Science Biosensor Diagnostics Pty Ltd Life
10% owner
Sep 22, 2021Sale−100,000$2.80$280.00K4,956,248
Science Biosensor Diagnostics Pty Ltd Life
10% owner
Sep 21, 2021Sale−100,000$2.83$283.00K5,056,248
Science Biosensor Diagnostics Pty Ltd Life
10% owner
Sep 20, 2021Sale−100,000$2.90$290.00K5,156,248

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
2.16%
0M shares short
Days to cover
3.1
At 0M shares a day
Change since last report
-30.3%
From 0M shares
Short volume, 20 days
47.7%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Intelligent Bio Solutions's stock actually held short. Settlement fails (shares not delivered on time) peaked at 59,283 shares on Sep 2, 2026 over the last 90 days.

See a number that looks wrong?